Freshwater-Reared Finfish Health
A bacterial outbreak can have negative outcomes for freshwater-reared finfish health. When you need to treat, take control with AQUAFLOR® (florfenicol) type A medicated feed article.
Key Benefits of AQUAFLOR®
- Reduces mortality and keeps fish on feed for optimal growth and survival
- Broad-spectrum antibiotic developed specifically for aquaculture – not used in human medicine
- Can be fed in any life stage from fingerlings to food fish
- May be used in sinking or floating feeds
- AQUAFLOR is a heat-stable molecule during feed manufacturing, including extrusion, as well as storage
- 15-day withdrawal time for all species at all approved dosages
- Approved for use in recirculating aquaculture systems
In freshwater-reared finfish, AQUAFLOR is approved for the control of mortality due to columnaris disease associated with Flavobacterium columnare.
Palatable
- Fish readily consume medicated feed – studies show palatability compared to unmedicated feed
- Minimize wasted feed while maximizing antibiotic uptake
- Uniform granulation offers more accurate dosage delivery and optimum distribution in the medicated feed
Safe
- No adverse effects on fish behavior or performance, even when fed at 10 times the recommended dose rate1
AquaBulletins
Determining Antimicrobial MICs Against Aquaculture Pathogens Using Sensititre® Plates
Author: Dr. Patricia S. Gaunt, DVM, PhD, DABVT
DownloadResearch
Efficacy of AQUAFLOR (50% florfenicol) – Medicated Feed to Control Mortality Associated with Flavobacterium columnare Infection in Florida Largemouth Bass and Bluegill
DOWNLOAD
Where to Buy AQUAFLOR
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
References
- See product bulletin for more details
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global